Aries Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Sell
13,659
-16
-0.1% -$1.4K 0.25% 85
2026
Q1
$1.17M Sell
13,675
-387
-3% -$34.5K 0.26% 83
2025
Q4
$1.11M Sell
14,062
-95
-0.7% -$7.45K 0.25% 86
2025
Q3
$1.13M Buy
14,157
+285
+2% +$24.3K 0.27% 87
2025
Q2
$1.26M Sell
13,872
-27
-0.2% -$2.46K 0.33% 77
2025
Q1
$1.3M Hold
13,899
0.35% 70
2024
Q4
$1.26M Sell
13,899
-5
-0% -$477 0.35% 70
2024
Q3
$1.44M Sell
13,904
-78
-0.6% -$7.95K 0.4% 61
2024
Q2
$1.36M Sell
13,982
-273
-2% -$25.2K 0.43% 60
2024
Q1
$1.28M Sell
14,255
-1,230
-8% -$104K 0.41% 64
2023
Q4
$1.23M Sell
15,485
-124
-0.8% -$9.32K 0.44% 62
2023
Q3
$1.13M Buy
15,609
+68
+0.4% +$5.08K 0.44% 64
2023
Q2
$1.2M Buy
15,541
+3
+0% +$232 0.46% 62
2023
Q1
$1.17M Sell
15,538
-22
-0.1% -$1.64K 0.48% 64
2022
Q4
$1.23M Hold
15,560
0.53% 57
2022
Q3
$1.15M Sell
15,560
-337
-2% -$26.4K 0.51% 57
2022
Q2
$1.27M Buy
+15,897
New +$1.24M 0.58% 48
2022
Q1
Sell
-16,057
Closed -$1.37M 99
2021
Q4
$1.37M Buy
16,057
+144
+0.9% +$11.2K 0.52% 55
2021
Q3
$1.2M Buy
15,913
+535
+3% +$42.5K 0.51% 54
2021
Q2
$1.25M Buy
15,378
+5
+0% +$409 0.54% 51
2021
Q1
$1.22M Sell
15,373
-753
-5% -$59K 0.55% 49
2020
Q4
$1.33M Hold
16,126
0.66% 42
2020
Q3
$1.24M Buy
16,126
+140
+0.9% +$10.7K 0.71% 40
2020
Q2
$1.17M Buy
15,986
+806
+5% +$57.3K 0.71% 42
2020
Q1
$1.03M Buy
15,180
+410
+3% +$28.9K 0.79% 38
2019
Q4
$1.01M Hold
14,770
0.62% 43
2019
Q3
$1.04M Sell
14,770
-78
-0.5% -$5.66K 0.69% 42
2019
Q2
$1.09M Sell
14,848
-73
-0.5% -$5.18K 0.76% 40
2019
Q1
$1.02M Buy
14,921
+95
+0.6% +$6.14K 0.76% 42
2018
Q4
$882K Buy
14,826
+40
+0.3% +$2.5K 0.94% 39
2018
Q3
$990K Hold
14,786
0.89% 35
2018
Q2
$991K Sell
14,786
-380
-3% -$24.9K 0.92% 32
2018
Q1
$1.09M Buy
15,166
+270
+2% +$19.4K 1.05% 32
2017
Q4
$1.15M Buy
+14,896
New +$1.09M 1.06% 28

Other funds holding CL

Aries Wealth Management's CL Position: Q2 2026 in Review

Aries Wealth Management reduced its Colgate-Palmolive (CL) stake by 0.12% in Q2 2026, selling an estimated $1.4K and leaving 13,659 shares worth $1.25M. The position accounts for 0.25% of the portfolio, ranked #85.

Aries Wealth Management first reported a position in CL in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.44M in Q3 2024. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Aries Wealth Management held 13,659 shares of Colgate-Palmolive worth $1.25M as of Q2 2026.
  • Aries Wealth Management sold 16 Colgate-Palmolive shares in Q2 2026, an estimated $1.4K.
  • Colgate-Palmolive made up 0.25% of Aries Wealth Management's portfolio in Q2 2026, its #85 holding.
  • Aries Wealth Management first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 34 quarters since.
  • Aries Wealth Management's Colgate-Palmolive position peaked at $1.44M in Q3 2024.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Aries Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.